"The U.S. Food and Drug Administration today approved Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an uncommon form of ALL.
Precursor B-cell A"...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
CLOFARABINE - INJECTION
COMMON BRAND NAME(S): Clolar
USES: Clofarabine is used to treat a certain type of cancer (acute lymphoblastic leukemia-ALL) in children and young adults ages 1 to 21 whose cancer has not been successfully treated by at least 2 other treatments. It works by stopping the growth of cancer cells.
HOW TO USE: This medication is given by injection into a vein by a health care professional.
Drink plenty of fluids to prevent serious problems due to a loss of too much body water (dehydration).
Dosage is based on your medical condition, body size, and response to treatment. This medication is usually given over 2 hours once a day for 5 days in a row or as directed by your doctor. A 5-day course of this medication is called a cycle. This cycle is repeated every 2 to 6 weeks depending on your response.
Avoid getting the medication on the skin or in the eyes, mouth, or nose. If you do get the medication in those areas, flush with plenty of water and tell your doctor immediately.
Additional Clolar Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.